Nuchal translucency scan: Purpose, procedure, and results

What is a nuchal translucency scan?

A nuchal translucency scan, often shortened to an NT scan, is a specialized ultrasound performed near the end of the first trimester. It measures a thin, fluid-filled space beneath the skin at the back of the fetus’s neck.

A small amount of fluid in this area is normal. During early development, every fetus has some visible nuchal translucency. When the space measures larger than expected for the fetus’s gestational age and size, however, it may be associated with a higher chance of a chromosomal condition or certain physical differences.

The test is noninvasive. It does not remove fluid, collect fetal tissue, or poke anything near the pregnancy. Despite the rather futuristic name, “translucency” simply refers to how the fluid-filled area appears on an ultrasound image.

An NT scan is a screening test rather than a diagnostic test. It calculates risk; it does not prove that a fetus has or does not have a medical condition. Think of it as an early warning system, not a courtroom verdict.

Evidence:

What is the purpose of a nuchal translucency scan?

The primary purpose of the scan is to help estimate the likelihood of certain chromosomal abnormalities. An increased NT measurement can be associated with:

• Down syndrome, also called trisomy 21
• Edwards syndrome, also called trisomy 18
• Patau syndrome, also called trisomy 13
• Turner syndrome and some other chromosome differences
• Certain genetic syndromes
• Congenital heart defects
• Some skeletal, abdominal wall, or other structural abnormalities

An enlarged measurement does not automatically mean that any of these conditions are present. Many pregnancies with an increased NT measurement ultimately have reassuring diagnostic tests and healthy outcomes. Likewise, a typical measurement cannot guarantee that every chromosome and organ is developing normally.

Additional information obtained during the scan

Although the neck measurement receives top billing, the appointment can provide other useful information. Depending on the clinic, equipment, gestational age, and fetal position, the sonographer may also:

• Confirm fetal cardiac activity
• Measure the fetus from crown to rump
• Help confirm the estimated due date
• Determine whether the pregnancy includes one fetus or multiples
• Look at early development of the skull, limbs, abdominal wall, and other structures
• Assess the fetal nasal bone
• Examine the uterus and placenta

The NT ultrasound is not a substitute for the detailed anatomy scan generally performed during the second trimester. At this early stage, many structures are still tiny, developing, and apparently determined to make the sonographer work for every useful image.

Evidence:

When is the nuchal translucency scan performed?

The nuchal translucency scan is typically performed between approximately 11 weeks and 13 weeks, 6 days of pregnancy. Some medical centers describe the window more broadly as 11 to 14 weeks.

Timing matters because the measurement must be taken when the fetus is within an appropriate size range. Many programs use a crown-rump length of roughly 45 to 84 millimeters. Before that point, the fetus may be too small for an accurate measurement. After about 14 weeks, the fluid can be reabsorbed, making the NT space more difficult to evaluate reliably.

Because the useful window is narrow, patients should schedule the appointment promptly after discussing first-trimester screening with their prenatal care provider. Missing the window does not mean prenatal screening is over. Cell-free DNA screening, second-trimester blood tests, and later ultrasounds may still be available, depending on the circumstances.

Evidence:

Who should be offered an NT scan?

Prenatal genetic screening and diagnostic testing options should be discussed with all pregnant patients, regardless of age or whether the pregnancy is considered high risk. A person may choose to have screening, choose diagnostic testing, or decline testing after receiving appropriate information.

An NT scan may be especially useful when a patient wants early information about fetal anatomy, is having combined first-trimester screening, has a family or pregnancy history that raises concern, or wants an ultrasound assessment in addition to cell-free DNA screening.

Personal values matter. Some families want as much prenatal information as possible. Others prefer only routine ultrasounds, while some decline genetic screening entirely. There is no universal emotional response or single correct choice. Good prenatal counseling should explain what each test can reveal, what it cannot reveal, and what decisions might follow an unexpected result.

Evidence:

How to prepare for a nuchal translucency ultrasound

Most patients do not need to fast, stop medications, or make major changes before the appointment. However, preparation instructions vary by facility.

Ask whether you need a full bladder

A moderately full bladder can improve the view during a transabdominal ultrasound by changing the position of the uterus and helping sound waves travel through the pelvis. A clinic may ask you to drink two or three glasses of water before the scan and avoid urinating until the examination is complete.

Do not create your own Olympic-level hydration challenge unless the clinic tells you to. An painfully overfilled bladder is not a bonus feature. If a transvaginal ultrasound is needed, the sonographer will generally ask you to empty your bladder first.

Bring relevant medical information

It may help to bring previous ultrasound reports, blood-screening results, medication information, and details about genetic conditions in either biological family. Patients who have already completed noninvasive prenatal testing should tell the imaging team, although the blood test does not interfere with the NT ultrasound.

Consider writing down questions before the appointment. Pregnancy appointments have a remarkable ability to make carefully prepared questions vanish the moment someone turns on an ultrasound monitor.

Evidence:

What happens during the NT scan?

Step 1: Positioning and ultrasound gel

For a transabdominal scan, the patient lies on an examination table with the abdomen exposed. The sonographer applies ultrasound gel and moves a handheld device called a transducer over the skin. The transducer sends high-frequency sound waves into the body and converts returning echoes into images.

The gel may feel cold unless the clinic warms it. The transducer may create mild pressure, particularly when the bladder is full, but the scan should not normally be painful.

Step 2: Finding the correct fetal position

Accurate NT measurement requires a precise side-view image of the fetus, with the head and upper body in a neutral position. The sonographer enlarges the image and carefully distinguishes the fetal skin from nearby tissues.

The measurement itself is taken across the widest part of the clear space behind the neck. More than one image may be captured to confirm accuracy.

Sometimes the fetus is curled up, facing the wrong direction, bouncing enthusiastically, or apparently refusing all media appearances. The sonographer may ask the patient to change position, cough, take a short walk, or wait a few minutes. A transvaginal scan may be offered if the abdominal view is unclear.

Step 3: Checking other early structures

The imaging professional may measure the crown-rump length, record the fetal heart rate, look for the nasal bone, and review visible anatomy. A maternal-fetal medicine physician or radiologist may examine the images before the appointment ends.

The total visit often lasts longer than the few seconds required to place the measurement markers. Fetal position, multiple pregnancy, body anatomy, uterine position, scar tissue, and image quality can all affect how easily the required view is obtained.

Evidence:

Is the nuchal translucency scan safe?

The NT scan uses ultrasound rather than ionizing radiation. Standard diagnostic ultrasound has no known risk to the pregnant patient or fetus when performed for a medical reason by trained professionals.

An abdominal scan is noninvasive. A transvaginal scan may cause temporary pressure or mild discomfort, but the probe remains in the vagina and does not enter the uterus or touch the fetus.

The scan itself does not cause miscarriage. This is different from diagnostic procedures such as chorionic villus sampling and amniocentesis, which collect placental or amniotic fluid samples and carry small procedure-related risks that should be discussed individually.

Evidence:

How are nuchal translucency results reported?

The sonographer records the thickness of the nuchal translucency in millimeters. The measurement is interpreted in relation to gestational age and crown-rump length because NT thickness naturally increases as the fetus grows.

There is not one universal cutoff that applies to every fetus, clinic, and screening program. Some centers compare the measurement with a gestational-age percentile. Others use a fixed threshold as one component of clinical decision-making.

At around 12 weeks, a measurement above approximately 3 millimeters often prompts a discussion about additional evaluation. Some programs use 3.0 or 3.5 millimeters, the 95th percentile, or the 99th percentile as a threshold. The exact interpretation should come from the clinician who has the complete ultrasound and pregnancy information.

Understanding a risk estimate

Results may be described as “low risk,” “increased risk,” “screen negative,” or “screen positive.” Combined screening may also produce a ratio, such as 1 in 1,000 or 1 in 100.

A result of 1 in 100 does not mean the fetus is 100% affected, nor does it mean that exactly one particular fetus in a group has the condition. It represents an estimated probability based on factors included in the calculation.

A lower-risk result is reassuring, but it does not eliminate every possible chromosomal, genetic, developmental, or structural condition. Screening tests are very useful filters, but they are not crystal balls with medical billing codes.

Evidence:

How NT results are combined with blood screening

The NT measurement may be used alone, but it has traditionally been combined with a first-trimester blood test. The blood test commonly measures pregnancy-associated plasma protein A, known as PAPP-A, and human chorionic gonadotropin, or hCG.

The ultrasound findings, blood markers, gestational age, and maternal age are entered into a calculation that estimates the chance of trisomy 21 and, depending on the program, trisomy 18 or trisomy 13. Combining information generally detects more affected pregnancies than using the NT measurement alone.

NT scan versus NIPT

Noninvasive prenatal testing, also called NIPT or cell-free DNA screening, analyzes DNA fragments circulating in the pregnant patient’s blood. It is a more sensitive screening method for common trisomies than NT measurement alone.

However, the tests provide different kinds of information. NIPT evaluates the likelihood of selected chromosome conditions but does not create an image of the fetus. An ultrasound may identify dating discrepancies, multiple gestation, pregnancy loss, or structural findings that a blood test cannot show.

Patients should discuss which screening pathway is appropriate rather than ordering several overlapping blood screens without a coordinated plan. Screening strategies, insurance coverage, laboratory methods, and clinical recommendations can differ.

Evidence:

What happens if the NT measurement is elevated?

An elevated measurement is not a diagnosis. The next step is usually a careful conversation about the degree of enlargement, other ultrasound findings, previous screening results, family history, gestational age, and the patient’s preferences.

Follow-up options may include:

• Consultation with a genetic counselor
• A more detailed ultrasound examination
• Cell-free DNA screening if it has not already been performed
• Chorionic villus sampling, usually performed in the first trimester
• Amniocentesis, generally performed later in pregnancy
• Chromosomal microarray or other genetic analysis when clinically appropriate
• A detailed anatomy ultrasound at approximately 18 to 22 weeks
• A fetal echocardiogram to examine the developing heart

CVS and amniocentesis are diagnostic procedures because they test cells from the pregnancy. They can provide a much more definitive answer about chromosome conditions than screening, although no test can identify every possible medical or developmental difference.

Current obstetric guidance recommends offering genetic counseling, diagnostic testing, and comprehensive ultrasound evaluation when an enlarged NT or another fetal anomaly is identified. The plan should be individualized rather than selected by panic, internet rabbit holes, or the loudest person in a family group chat.

Evidence:

Common questions about nuchal translucency screening

Can the NT scan diagnose Down syndrome?

No. It can indicate a higher or lower estimated chance of Down syndrome, but CVS or amniocentesis is needed for prenatal diagnosis.

Does a normal NT measurement guarantee a healthy baby?

No screening result can provide that guarantee. A typical measurement lowers concern for certain conditions but does not exclude all chromosome abnormalities, genetic syndromes, heart defects, or structural differences.

Can the scan reveal fetal sex?

The NT scan is not designed to determine fetal sex. The anatomy is still developing, and early ultrasound predictions may be unreliable. Cell-free DNA screening or a later anatomy ultrasound may provide more accurate information when desired.

Can the scan be repeated?

If the sonographer cannot obtain the correct view and the pregnancy remains within the approved measurement window, the clinic may arrange another attempt. A repeat appointment does not necessarily mean that anything is wrong; sometimes the fetus simply did not cooperate.

What if the appointment is missed?

Once the fetus is beyond the appropriate size and gestational window, an NT measurement may no longer be reliable. The prenatal care provider can discuss other screening and imaging options.

Evidence:

What the NT scan experience may feel like

The technical explanation is useful, but it does not fully capture the experience of lying in a dim room while a sonographer studies a grainy screen. The following situations are realistic composites rather than quotations from specific patients.

Experience 1: A routine scan that takes longer than expected

A patient arrives at 12 weeks with a carefully filled bladder, checks in, and immediately begins wondering whether drinking the final glass of water was an act of reckless optimism. During the scan, the fetal heartbeat appears quickly, but the fetus is curled forward, making the neck difficult to measure.

The sonographer asks the patient to roll onto one side, then the other. There is a short walk down the hallway and another attempt. Eventually, the fetus stretches into the right position, and the sonographer captures the required images.

The measurement is within the expected range. Relief arrives, but so does an important reminder: a reassuring NT result is one part of prenatal care, not a guarantee. The patient still plans to complete the recommended anatomy ultrasound later in pregnancy.

Experience 2: An elevated measurement followed by more testing

Another patient expects a routine appointment but learns that the NT measurement is larger than expected. The word “elevated” makes everything after it sound distant and muffled.

The maternal-fetal medicine specialist explains that the finding is a risk marker, not a diagnosis. The patient’s previous cell-free DNA result was low risk, which is reassuring, but an enlarged NT can also be associated with heart defects and genetic conditions that standard NIPT does not evaluate.

A genetic counselor reviews the available options without forcing a decision. The patient chooses diagnostic testing and schedules detailed fetal imaging. Waiting for results is emotionally difficult, but having a clear plan feels better than trying to interpret isolated numbers online at 2 a.m.

The diagnostic chromosome testing is normal, and follow-up imaging is reassuring. The experience remains stressful, but the elevated measurement did not ultimately translate into a diagnosed condition.

Experience 3: Choosing not to pursue additional screening

A third patient discusses NT screening with a clinician and decides not to have it. The patient understands what the scan could reveal, what follow-up might involve, and which routine ultrasounds will still be offered.

This decision is made after counseling rather than from lack of information. For this family, the result would not change pregnancy management, and additional screening would create more anxiety than reassurance.

Another family might make the opposite choice for equally thoughtful reasons. Some people want time to prepare emotionally, arrange specialty care, plan where to deliver, or learn about a condition before birth. Others prefer to avoid optional screening. Respectful prenatal care leaves room for both approaches.

Practical lessons from the appointment

Patients often find it helpful to ask when the preliminary ultrasound result will be discussed, how long related blood results may take, and whom to contact with questions. Bringing a partner or support person may help, although clinic policies differ.

It is also reasonable to ask for unfamiliar terms to be explained in plain language. “What does this result mean for this pregnancy?” is often more useful than focusing on one number without context.

Most importantly, an unexpected measurement should not be treated as a final answer. The NT scan opens a conversation. Follow-up testing, detailed imaging, and expert counseling provide the context needed to understand what the early finding mayor may notmean.

Conclusion

A nuchal translucency scan is an optional first-trimester ultrasound that measures fluid behind the fetal neck. It can help estimate the chance of Down syndrome, trisomy 18, trisomy 13, congenital heart defects, and certain other conditions while also providing an early look at fetal development.

The procedure is generally straightforward and carries no known risk from medically indicated ultrasound. Results must be interpreted according to fetal size, gestational age, other screening information, and the complete ultrasound examination.

A typical result can be reassuring, while an enlarged measurement calls for more information rather than immediate conclusions. Genetic counseling, diagnostic testing, detailed anatomy imaging, and fetal heart evaluation may help families and clinicians understand the finding and plan appropriate care.